BioCurex, Inc.(fka BOCX)

[GPKOCHMAN]

Admittedly, the company needs to get their reporting act together before they become a profitable organization. Once they become a profitable going concern is when financial restatements have serious repercussions on the stock price and investor confidence.

At present, it is a given that BOCX is cash consumer that is geared to run in the red. Because of that, a financial restatement for the adjusted value of mis-reported equities trades does not particularly bother me outside of the fact that the weakness in the process and audit trail leaves the door open for someone to rob the cookie jar.